Intech Investment Management LLC Ionis Pharmaceuticals Inc Transaction History

Intech Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Oct 18, 2024	SELL	$37.12 - $46.52 $246,105 - $308,427	-6,630 Reduced 11.6%	50,510 $1.91 Million
Q4 2022 Feb 09, 2023	SELL	$37.12 - $46.52 $246,105 - $308,427	-6,630 Reduced 11.6%	50,510 $1.91 Million
Q3 2022 Oct 18, 2024	BUY	$36.54 - $48.66 $2.09 Million - $2.78 Million	57,140 New	57,140 $2.53 Million
Q3 2022 Nov 10, 2022	BUY	$36.54 - $48.66 $2.09 Million - $2.78 Million	57,140 New	57,140 $2.53 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Intech Investment Management LLC with notifications on news.